May 14 (Reuters)- Noile-Immune Biotech Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Mar 31, 2026 Mar 31, 2025 Dec 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 2 mln (-17.2 pct) Operating loss 202 mln loss 241 mln Recurring loss 152 mln loss 239 mln Net loss 153 mln loss 240 mln EPS loss 3.54 yen loss 5.55 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Noile-Immune Biotech Inc.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T